Home > Investors > Results > Year Ending 1 April 2007

Preliminary Results for the Year Ended 1 April 2007

Synergy Healthcare plc (AIM: SYR), a leading international provider of sterilisation and infection control solutions for hospitals and the healthcare industry, announces its preliminary results for the year ended 1 April 2007.

• Turnover up 31% to £152.6 million (2006: £116.9 million)
• Underlying revenue, excluding Isotron, up 20% to £140 million
• Operating profit* up 43% to £18.8 million (2006: £13.1 million)
• Profit before tax* up 33% to £16.9 million (2006: £12.7 million)
• Operating cashflow up 29% to £35.5 million (2006: £27.6 million)
• Adjusted earnings per share* up 23% to 29.2p (2006: 23.8p)
• Basic earnings per share of 15.4p (2006: 20.40p)
• Due to non-recurring costs of £6.0 million relating to contested insurance claim and post-acquisition reorganisation costs
• Dividend per share for the full year up 20% to 8.4p (2006: 7.0p)

• Acquisition of Isotron completed in January 2007 and now successfully integrated
• Now focused on maximising growth opportunities by expanding Synergy’s hospital services in Europe and Asia
• Potential of strategy now seen as greater than previously envisaged
• Plans in place to raise Isotron’s organic growth rates to mid-teen Synergy levels over medium term
• New facilities to open in the Netherlands, France and China in the coming twelve months
• Strong growth by Patient Care in UK and the Netherlands
• New products and services, including AirCleanse™, AssurePlus™ and Exsudex™, launched to meet the growing demand for infection control solutions
• Surgical division continues to make progress with NHS National Decontamination bids and opportunities in Europe

Richard Steeves, Chief Executive of Synergy Healthcare, said:

“This has been another year of excellent underlying profit and earnings growth with a strong performance from all parts of Synergy’s business. The acquisition of Isotron completed during the year has now been successfully integrated and provides us with a platform to extend our hospital sterilisation services across Europe and into Asia. With the international healthcare market continuing to adopt outsourced sterilisation services, we are confident in the outlook for the coming year and believe that Synergy is well placed to achieve strong future growth.”

* Before amortisation and non-recurring items

Download

Preliminary Results for the Year Ended 1 April 2007 (Adobe PDF - 218Kb)